Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia. Yokoyama Y. Int J Hematol 2024 Feb 22. doi: 10.1007/s12185-023-03696.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yokoyama Y. Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia. Int J Hematol 2024 Feb 22. doi: 10.1007/s12185-023-03696.
PMID: 38386203